Flash Finance

Laxmi Dental LimitedLAXMIDENTLCorporate

Healthcare Latest results: Mar 2026 10 quarters of data
Consolidated Standalone
₹184.72
MCap ₹1,017 Cr · P/E 52.6
Laxmi Dental Limited — Stock analysis & AI research Laxmi Dental Limited — Multibagger AI analysis Laxmi Dental Limited — Seasonality — best & worst months Laxmi Dental Limited — Technical setup — score, trend, support & resistance Laxmi Dental Limited — Live exchange announcements
📋 High Profit Growth Stocks📋 Low Debt Stocks 📈 MACD Bearish Crossover📈 Bollinger Squeeze Stocks📈 20-Day Breakdown Stocks📈 Lowest Technical Score📈 Multi-Timeframe Bearish Stocks📈 Unusual Volume Stocks 🏭 Healthcare sector
AI-assisted data: figures and text on this page are extracted from public quarterly filings with AI assistance, checked automatically and overseen by our editorial team (human in the loop). They may still contain errors or omissions. Verify critical numbers against official company / SEBI / NSE / BSE filings before making any decision. Educational information only, not financial advice.
₹56 Cr
Sales · Mar 2026
+30.6% YoY
₹8 Cr
Operating Profit · Mar 2026
+9.3% YoY
14.4%
OPM % · Mar 2026
-16.3% YoY
₹7 Cr
Net Profit · Mar 2026
+62.9% YoY
₹1.24
EPS · Mar 2026
+61.0% YoY

📝 Laxmi Dental Limited — results explained

Quarter ended March 2026 (Q4 FY26)

Laxmi Dental Limited reported revenue of ₹56 crore for the quarter ended March 2026 (Q4 FY26), up 30.6% from ₹43 crore in the same quarter last year, and up 15.0% sequentially over the December 2025 quarter.

Net profit rose 62.9% year-on-year to ₹7 crore, from ₹4 crore. Earnings per share (EPS) came in at ₹1.24.

Operating profit stood at ₹8 crore — an operating margin (OPM) of 14.4%, compared with 17.2% in the year-ago quarter.

Full year and trailing twelve months

For the full year FY26, Laxmi Dental Limited posted revenue of ₹209 crore, a growth of 21.8% over FY25, with a net profit of ₹19 crore (down 25.0% year-on-year).

On a trailing-twelve-month (TTM) basis, revenue stands at ₹209 crore with a net profit of ₹19 crore.

Valuation snapshot

At the current price of ₹184.72, LAXMIDENTL has a market capitalisation of ₹1,017 crore and a trailing P/E of about 52.6.

Within the Healthcare industry, it is the 13th-largest of the 22 companies we track by market value.

Shareholding pattern

As of Jun 2026, promoters held 41.80%, foreign institutional investors (FIIs) 30.10%, domestic institutional investors (DIIs) 10.89%, public shareholders 17.21% of Laxmi Dental Limited.

📈 Share price & events

📊 Quarterly trend

₹ crore · OPM % on right axis

🎯 Key metrics

price-linked ratios use the latest close
Valuation
Market Cap ?
₹1,017 Cr
Current Price ?
₹184.7
P/E ?
52.57above ind
Industry P/E ?
34.70
P/B ?
4.12
P/S ?
4.87
P/FCF ?
-19.55
Enterprise Value ?
₹1,028 Cr
EV/EBITDA ?
33.98
PEG ?
0.21
Earnings Yield ?
1.8%
Dividend Yield ?
0.00%
Profitability & Returns
Sales (TTM) ?
₹209 Cr
OPM ?
14.5%
Profit after tax (TTM) ?
₹19 Cr
EPS (TTM) ?
₹3.51
ROCE ?
12.0%
ROE ?
7.8%
ROA ?
6.7%
Growth
Sales — latest qtr ?
₹56 Cr
PAT — latest qtr ?
₹7 Cr
YoY qtr sales growth ?
30.6%
YoY qtr profit growth ?
62.9%
Sales growth (3y) ?
18%
Sales growth (5y) ?
27%
Profit growth (3y) ?
246%
Profit growth (5y) ?
60%
Financial Health
Debt ?
₹11 Cr
Debt to Equity ?
0.04
Interest Coverage ?
24.0
Current Ratio ?
N/A
Ownership
Promoter holding ?
41.80%
Change in promoter holding ?
0.10%
Pledged percentage ?
N/A
Market
Return 3 months ?
-16.6%
Return 6 months ?
-5.3%

🗓️ Quarterly results (10 quarters · ₹ Cr)

same fiscal quarter as Mar bestweakest per row · for costs (interest, NPAs) low is best
Metric Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026 YoY % QoQ %
Sales 35394342434350544856 +30.6% +15.0%
Operating Profit 16856710858 +9.3% +75.7%
Other Income 341131233-22 -8.6% +193.9%
Interest 1111110000 -61.5% +17.4%
Depreciation 2222332333 +17.7% +8.8%
Profit Before Tax 1716536108-16 +0.3% +864.3%
Net Profit 261543487-27 +62.9% +459.8%
EPS 57.16193.575.251.370.590.771.431.20-0.341.24 +61.0% +464.7%
OPM % 3.2% 15.8% 19.6% 11.4% 12.9% 17.2% 19.9% 14.2% 9.4% 14.4% -16.3% +53.2%

📆 Annual results (₹ Cr, FY = Apr–Mar)

Metric FY25 FY26 TTM YoY %
Sales ₹171 Cr ₹209 Cr ₹209 Cr +21.8%
Operating Profit ₹26 Cr ₹30 Cr ₹30 Cr +15.5%
OPM % 15.29% 14.50% 14.50% -5.2%
NPM % 15.05% 9.27% 9.27% -38.4%
Other Income ₹16 Cr ₹6 Cr ₹6 Cr -64.0%
Depreciation ₹10 Cr ₹12 Cr ₹12 Cr +17.2%
Interest ₹4 Cr ₹1 Cr ₹1 Cr -78.6%
EBIT ₹16 Cr ₹19 Cr ₹19 Cr +14.5%
PBT ₹30 Cr ₹24 Cr ₹24 Cr -19.3%
Tax ₹4 Cr — — —
Net Profit ₹26 Cr ₹19 Cr ₹19 Cr -25.0%
EPS ₹7.98 ₹3.53 ₹3.53 -55.8%
Material Cost ₹24 Cr — — —
Employee Cost ₹33 Cr — — —
Extraordinary Items ₹0 Cr — — —

🏛️ Balance Sheet (latest 4 periods)

Metric Mar 2023Mar 2024Mar 2025Mar 2026 % Chg
Equity Capital 0.310.311111 +0.0%
Reserves 2851212236 +11.3%
Borrowings 4253511 +120.0%
Other Liabilities 37314831 -35.4%
Total Liabilities 108136276289 +4.7%
Fixed Assets 35334054 +35.0%
CWIP 0000 —
Investments 14141779 +364.7%
Other Assets 5989219156 -28.8%
Total Assets 108136276289 +4.7%

💧 Cash Flow (latest 4 periods)

Metric Mar 2023Mar 2024Mar 2025Mar 2026 % Chg
Cash from Operating Activity 10547-35 -174.5%
Cash from Investing Activity -6-6-49-46 +6.1%
Cash from Financing Activity -1-2104-3 -102.9%
Net Cash Flow 3-3102-85 -183.3%
Free Cash Flow 3-234-52 -252.9%
CFO/OP 156%45%180%-97% -153.9%

➗ Ratios (latest 4 periods)

Metric Mar 2023Mar 2024Mar 2025Mar 2026 % Chg
Debtor Days 85886854 -20.6%
Inventory Days 162196132111 -15.9%
Days Payable 1518219645 -77.0%
Cash Conversion Cycle 952014120 +2900.0%
Working Capital Days 207172201 +179.2%
ROCE % 6%19%17%12% -29.4%

👥 Shareholding (latest 5 periods)

Metric Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026 % Chg
Promoters 41.70%41.70%41.70%41.77%41.80% +0.1%
FIIs 33.59%32.39%32.45%31.20%30.10% -3.5%
DIIs 14.30%11.85%10.82%10.52%10.89% +3.5%
Public 10.39%14.05%15.01%16.50%17.21% +4.3%
No. of Shareholders 27,95737,90938,63538,16136,937 -3.2%

⚖️ Peer comparison

Industry: Healthcare · 22 companies · full page →
# Company CMP MCap (Cr) P/E Sales TTM NP TTM OPM% NPM% Sales YoY% NP YoY% Qtr Rev Δ% Qtr NP Δ%
1 VIJAYA Vijaya Diagnostic ₹1,507.80 15,530 82.7 857 187 42.3% 21.8% 19.5% 20.2% 22.8% 37.3%
2 METROPOLIS Metropolis Healthcare ₹596.30 12,370 61.1 1,710 203 24.7% 11.9% 23.6% 31.4% 16.6% 25.7%
3 HCG Healthcare Global ₹704.05 10,512 390.9 2,626 33 18.2% 1.3% 14.6% -53.3% 13.1% 175.3%
4 YATHARTH Yatharth Hospital ₹988.90 9,528 54.1 1,200 171 23.6% 14.3% 36.2% 31.6% 47.6% 16.2%
5 JLHL Jupiter Life ₹277.85 9,109 9.7 1,557 187 22.1% 12.0% 20.9% -6.7% 18.2% -14.5%
6 THYROCARE Thyrocare Technologies ₹555.45 8,841 50.0 876 176 32.1% 20.1% 20.8% 79.4% 24.3% 33.2%
7 KOVAI Kovai Medical ₹6,260.50 6,850 26.7 1,644 256 27.9% 15.6% 15.7% 16.7% 15.3% 20.6%
8 INDRAMEDCO Indraprastha Medical ₹363.20 3,330 17.7 1,524 188 18.0% 12.4% 9.3% 13.7% 11.3% 9.5%
9 KRSNAA Krsnaa Diagnostics ₹543.40 1,763 18.1 816 98 26.8% 12.0% 7.8% 31.0% 22.1% -19.3%
10 SURAKSHA Suraksha Diagnostic ₹311.85 1,624 45.3 325 35 31.4% 10.8% 23.1% 1.4% 20.7% 40.0%
11 SHALBY Shalby ₹132.15 1,418 38.0 1,176 37 12.1% 3.2% 5.0% 1683.0% 11.7% 36.7%
12 GPTHEALTH GPT Healthcare ₹157.90 1,296 27.4 491 48 18.5% 9.8% 15.1% -21.9% 17.8% 62.5%
13 LAXMIDENTL Laxmi Dental ₹196.21 1,080 35.0 287 31 16.2% 10.9% 16.0% -10.1% 13.2% 28.9%
14 NEPHROCARE Nephro Care ₹234.80 387 — — — — — — — 68.4% 347.7%
15 LOTUSEYE Lotus Eye ₹114.50 243 n/m 57 0 8.5% 0.3% 8.4% -89.1% 26.2% 13.0%
16 UNIHEALTH Unihealth Hospitals ₹121.00 190 6.5 132 46 40.9% 34.8% — — 104.6% 71.5%
17 MADHAVBAUG Vaidya Sane ₹148.00 156 19.1 147 8 11.4% 5.6% — — 116.1% 94.3%
18 MHHL Mohini Health ₹57.05 104 — 145 -17 -1.4% -11.7% — — -6.6% -1400.0%
19 MAITREYA Maitreya Medicare ₹120.65 82 — 45 -2 -1.0% -5.5% — — -5.2% -1720.0%
20 AATMAJ Aatmaj Healthcare ₹26.75 60 83.6 24 1 9.7% 2.9% — — 22.5% -39.4%
21 NIDAN Nidan Laborator. ₹33.00 46 30.6 26 2 19.0% 5.9% — — -11.2% -92.0%
22 ARTEMISMED Artemis Medicare ₹315.00 — 48.0 1,081 103 17.4% 9.6% 15.4% 25.9% 16.3% 30.9%
❓ Frequently asked questions
What was Laxmi Dental Limited's revenue in Q4 FY26?
Laxmi Dental Limited reported revenue of ₹56 crore for the quarter ended March 2026 (Q4 FY26), up 30.6% from ₹43 crore in the same quarter last year, and up 15.0% sequentially over the December 2025 quarter.
What was Laxmi Dental Limited's net profit in Q4 FY26?
Net profit rose 62.9% year-on-year to ₹7 crore, from ₹4 crore. Earnings per share (EPS) came in at ₹1.24.
What is LAXMIDENTL's market capitalisation and P/E ratio?
At the current price of ₹184.72, LAXMIDENTL has a market capitalisation of ₹1,017 crore and a trailing P/E of about 52.6.
Who owns Laxmi Dental Limited? (shareholding pattern)
As of Jun 2026, promoters held 41.80%, foreign institutional investors (FIIs) 30.10%, domestic institutional investors (DIIs) 10.89%, public shareholders 17.21% of Laxmi Dental Limited.
TTM ends 2026-03-31. Amounts are ₹ crore unless stated otherwise. Figures are extracted by AI from public quarterly filings; gaps are filled from public market data. Live price refreshed about twice a day from exchange data. Educational information only — not financial advice.
⚠️ How this site is made: Market data pages are computed automatically from NSE/BSE publications and company filings; news articles and announcement analyses are written with AI assistance, with a human in the loop: our editors review what the AI produces. Both can contain errors. Verify with the original sources before any investment decision. Not investment advice; Flash Finance is not SEBI-registered. How we use AI